HK1005877A1 - Cyclopentanperhydrophenanth ren-17beta-(3-furyl)-3- derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders - Google Patents

Cyclopentanperhydrophenanth ren-17beta-(3-furyl)-3- derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders

Info

Publication number
HK1005877A1
HK1005877A1 HK98104945A HK98104945A HK1005877A1 HK 1005877 A1 HK1005877 A1 HK 1005877A1 HK 98104945 A HK98104945 A HK 98104945A HK 98104945 A HK98104945 A HK 98104945A HK 1005877 A1 HK1005877 A1 HK 1005877A1
Authority
HK
Hong Kong
Prior art keywords
furyl
derivatives
treatment
pharmaceutical compositions
cyclopentanperhydrophenanth
Prior art date
Application number
HK98104945A
Other languages
English (en)
Inventor
Luisa Quadri
Luigi Bernardi
Patrizia Ferrari
Mauro Gobbini
Piero Melloni
Loredana Valentino
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1005877A1 publication Critical patent/HK1005877A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0021—Oxiranes at position 14(15)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK98104945A 1992-07-01 1998-06-05 Cyclopentanperhydrophenanth ren-17beta-(3-furyl)-3- derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders HK1005877A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4221636A DE4221636C1 (de) 1992-07-01 1992-07-01 Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate

Publications (1)

Publication Number Publication Date
HK1005877A1 true HK1005877A1 (en) 1999-01-29

Family

ID=6462265

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104945A HK1005877A1 (en) 1992-07-01 1998-06-05 Cyclopentanperhydrophenanth ren-17beta-(3-furyl)-3- derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders

Country Status (9)

Country Link
US (2) US5432169A (xx)
EP (1) EP0576915B1 (xx)
JP (1) JPH0665284A (xx)
AT (1) ATE151774T1 (xx)
DE (2) DE4221636C1 (xx)
DK (1) DK0576915T3 (xx)
ES (1) ES2099865T3 (xx)
GR (1) GR3023310T3 (xx)
HK (1) HK1005877A1 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
DE4232656C2 (de) * 1992-09-29 1995-01-12 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17-furyl-3ß-derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
CA2173729C (en) * 1993-10-27 2001-05-15 Norton P. Peet .delta.16 unsaturated c17 heterocyclic steroids useful as steroid c17-20 lyase inhibitors
IT1282286B1 (it) * 1995-05-11 1998-03-16 Sigma Tau Ind Farmaceuti Seco-d steroidi sul sistema cardiovascolare, processi per la loro preparazione e composizioni farmaceutiche che li contengono.
IT1282289B1 (it) * 1995-06-23 1998-03-16 Sigma Tau Ind Farmaceuti 17-idrossiimminoalchil e 17-idrossiimminometilalchenil ciclopentaperidrofenantreni attivi sul sistema cardiovascolare,
JP3875125B2 (ja) * 2001-04-11 2007-01-31 シャープ株式会社 液晶表示装置
US20040064050A1 (en) * 2002-09-20 2004-04-01 Jun Liu System and method for screening tissue
PT1951738E (pt) * 2005-11-25 2012-04-18 Rostaquo S P A Novas formas cristalinas de rostafuroxin
ES2949701T3 (es) 2018-07-26 2023-10-02 Cvie Therapeutics Ltd Compuestos similares al 17beta-heterociclil-digitalis para el tratamiento de la insuficiencia cardíaca

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227015B (de) * 1963-01-23 1966-10-20 Bayer Ag Verfahren zur Herstellung von 3beta-Hydroxy-(bzw.-Acyloxy)-steroid-20-amidylhydrazonen der Pregnanreihe
GB1081647A (en) * 1965-04-01 1967-08-31 Shionogi & Co Furan compounds
US3436390A (en) * 1966-05-24 1969-04-01 American Home Prod 4,4-dihydroxy-2-butenoic acid lactones
DE1807585C3 (de) * 1968-11-04 1974-11-07 Schering Ag, 1000 Berlin Und 4619 Bergkamen 14,15beta-Epoxycardenolide, Verfahren zu deren Herstellung und diese enthaltende Mittel
DE1812946C3 (de) * 1968-12-05 1978-11-02 Hoechst Ag, 6000 Frankfurt Herzwirksame 14beta, lSbeta Oxidobutatrienolide und Verfahren zu ihrer Herstellung
US4259240A (en) * 1979-09-28 1981-03-31 Advance Biofactures Corporation Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom
GB8916636D0 (en) * 1989-07-20 1989-09-06 Erba Carlo Spa Steroid ethers
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate

Also Published As

Publication number Publication date
US5432169A (en) 1995-07-11
US5593982A (en) 1997-01-14
JPH0665284A (ja) 1994-03-08
EP0576915B1 (en) 1997-04-16
EP0576915A2 (en) 1994-01-05
DE69309790D1 (de) 1997-05-22
DE69309790T2 (de) 1997-09-11
DK0576915T3 (da) 1997-09-01
GR3023310T3 (en) 1997-08-29
DE4221636C1 (de) 1994-03-31
ES2099865T3 (es) 1997-06-01
ATE151774T1 (de) 1997-05-15
EP0576915A3 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
IL121170A0 (en) Compositions for the treatment of dermatological disorders
HK1012559A1 (en) Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis.
HK1002898A1 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1benzopyranes
GR3023310T3 (en) Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
EP1032556A4 (en) PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
IL89352A0 (en) Milk anti-hypertensive factor,method for the production thereof and pharmaceutical compositions containing the same
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
BG102667A (en) Diosgenine-containing composition
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
PL322284A1 (en) Derivatives of aminoteralin useful in treating diseases of cardiovascular system
EP0273310A3 (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
IL111144A0 (en) Pharmaceutical compositions containing amiodarone for the treatment of heart failure
GR3024707T3 (en) Digitoxigenin and dihydrodigitoxigenin 3beta-derivatives and pharmaceutical compositions comprising same for the treatment of cardiovascular disorders
IL89901A0 (en) Strobilurine derivatives
GR3025064T3 (en) New hydrazino and hydroxyamino-14beta-hydroxyandrostane derivatives active on the cardio-vascular system, processes for their preparation and pharmaceutical compositions containing same
EP0579077A3 (en) 1,3,4-thiadiazinones for the treatment of cardiovascular diseases
GR3031908T3 (en) Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
AU617277B2 (en) 2-alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia
IL79944A0 (en) N-substituted 3,4-dihydropyrimidine derivatives and pharmaceutical compositions for treating disorders of the cardiovascular system
ZA863914B (en) 1,4-dihydropyridine derivatives useful for the treatment of cardiovascular disorders
GR3029466T3 (en) 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
ITFI930001A1 (it) Medicamento per il trattamento dell'asma.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)